niftify.in

Business Line

Taking critical diagnostics services right to people’s doorsteps

Molbio Diagnostics aims to revolutionize healthcare with portable medical devices, targeting a ₹2,000 crore turnover in 4-5 years CEO Sriram Natarajan said that he would like the company to play a much bigger role, where it can pull in a lot of ideas and resources, and truly take it to the global level

Mint

Expert View: SMIDs to gain from rate cuts; Nifty 50 may deliver low-teen return: Baroda BNP Paribas MF's Jitendra Sriram

The leverage for the SMID space is usually higher, and they would be bigger beneficiaries of a rate-easing cycle as it gets underway, says Jitendra Sriram of Baroda BNP Paribas Mutual Fund.

CNBC TV18

Barclays economist rules out US recession

Historically, equities have had a little difficulty around the first cut of a rate-cutting cycle, so it is quite likely that they remain rangebound until there is some clarity next week, according to Pooja Sriram, US Economist at Barclays.

The Economic Times

Today's MSCI index rejig can bring $5.5 billion to D-Street

"MSCI's August 2024 review changes for its standard and small-cap indices will be implemented on Friday, likely leading to $5.5 billion in net inflows," said Sriram Velayudhan, head of alternative research at IIFL. "This includes adjustments to country weightings, with India expected to gain substantially post-rebalancing."